Benjamin Dryden Discusses Kroger-Albertsons Antitrust Review with Wall Street Journal
21 October 2022
Foley & Lardner LLP Partner Benjamin Dryden is quoted in The Wall Street Journal article, “Kroger-Albertsons Antitrust Review Likely to Focus on Local Store Overlap,” discussing what antitrust authorities reviewing the planned $20 billion merger will consider significant.
Dryden said competition authorities typically look within a radius of between two to 10 miles to measure grocery markets and exclude discounters, like dollar stores, from their analysis.
“The FTC is going to take this very seriously,” he added.
(Subscription required)
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”